ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease
- PMID: 23255161
- DOI: 10.1093/hmg/dds535
ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease
Abstract
Inability to properly degrade unfolded or misfolded proteins in the endoplasmic reticulum (ER) leads to ER stress and unfolded protein response. This is particularly important in cases of diseases in which the mutant proteins undergo ER-associated degradation (ERAD), as in Gaucher disease (GD). GD is a genetic, autosomal recessive disease that results from mutations in the GBA1 gene, encoding the lysosomal enzyme acid β-glucocerebrosidase (GCase). We have shown that mutant GCase variants undergo ERAD, the degree of which is a major determinant of disease severity. Most ERAD substrates undergo polyubiquitination and proteasomal degradation. Therefore, one expects that mutant GCase variants are substrates for several E3 ubiquitin ligases in different cells. We tested the possibility that ITCH, a known E3 ubiquitin ligase, with a pivotal role in proliferation and differentiation of the skin, recognizes mutant GCase variants and mediates their polyubiquitination and degradation. Our results strongly suggest that ITCH interacts with mutant GCase variants and mediates their lysine 48 polyubiquitination and degradation.
Similar articles
-
Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.Hum Mol Genet. 2010 Oct 1;19(19):3771-81. doi: 10.1093/hmg/ddq292. Epub 2010 Jul 19. Hum Mol Genet. 2010. PMID: 20643691
-
Gaucher disease paradigm: from ERAD to comorbidity.Hum Mutat. 2012 Oct;33(10):1398-407. doi: 10.1002/humu.22124. Epub 2012 Jun 11. Hum Mutat. 2012. PMID: 22623374 Review.
-
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.Chem Biol. 2014 Aug 14;21(8):967-76. doi: 10.1016/j.chembiol.2014.06.008. Chem Biol. 2014. PMID: 25126989 Free PMC article.
-
Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.Orphanet J Rare Dis. 2014 Jun 16;9:86. doi: 10.1186/1750-1172-9-86. Orphanet J Rare Dis. 2014. PMID: 24935484 Free PMC article.
-
The relationship between glucocerebrosidase mutations and Parkinson disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860875 Free PMC article. Review.
Cited by
-
Animal Models for the Study of Gaucher Disease.Int J Mol Sci. 2023 Nov 7;24(22):16035. doi: 10.3390/ijms242216035. Int J Mol Sci. 2023. PMID: 38003227 Free PMC article. Review.
-
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.Biomolecules. 2023 Apr 3;13(4):644. doi: 10.3390/biom13040644. Biomolecules. 2023. PMID: 37189391 Free PMC article.
-
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992201 Free PMC article. Review.
-
TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.Neuron. 2021 Dec 1;109(23):3758-3774.e11. doi: 10.1016/j.neuron.2021.09.031. Epub 2021 Oct 12. Neuron. 2021. PMID: 34644545 Free PMC article.
-
Exploring genetic modifiers of Gaucher disease: The next horizon.Hum Mutat. 2018 Dec;39(12):1739-1751. doi: 10.1002/humu.23611. Epub 2018 Sep 11. Hum Mutat. 2018. PMID: 30098107 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
